| How to GRADE the quality of the evidence R Ryan, S Hill Cochrane consumers and communication group 3, 2016 | 498 | 2016 |
| Sodium channelopathies in neurodevelopmental disorders MH Meisler, SF Hill, W Yu Nature Reviews Neuroscience 22 (3), 152-166, 2021 | 138 | 2021 |
| Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome GM Lenk, P Jafar‐Nejad, SF Hill, LD Huffman, CE Smolen, JL Wagnon, ... Annals of neurology 87 (3), 339-346, 2020 | 129 | 2020 |
| The role of patient satisfaction surveys in a national approach to hospital quality management M Draper, S Hill AGPS, 1995 | 92 | 1995 |
| Antisense oligonucleotide therapy for neurodevelopmental disorders SF Hill, MH Meisler Developmental neuroscience 43 (3-4), 247-252, 2021 | 83 | 2021 |
| How to GRADE the quality of the evidence. Cochrane Consumers and Communication Group. 2016 R Ryan, S Hill | 60 | 2019 |
| How to GRADE the quality of the evidence. Cochrane Consumers and Communication Group, Version 3.0. 2016 R Ryan, S Hill | 37 | 2019 |
| CHD7 represses the retinoic acid synthesis enzyme ALDH1A3 during inner ear development H Yao, SF Hill, JM Skidmore, ED Sperry, DL Swiderski, GJ Sanchez, ... JCI insight 3 (4), e97440, 2018 | 35 | 2018 |
| CHD7 promotes neural progenitor differentiation in embryonic stem cells via altered chromatin accessibility and nascent gene expression H Yao, DF Hannum, Y Zhai, SF Hill, RDO Albanus, W Lou, JM Skidmore, ... Scientific reports 10 (1), 17445, 2020 | 32 | 2020 |
| How to GRADE the quality of the evidence. 2016 R Ryan, S Hill cccrg. cochrane. org/author‐resources, 2020 | 29 | 2020 |
| How to GRADE the quality of the evidence. Cochrane Consumers and Communication Group. Version 3.0 R Ryan, S Hill cccrg. cochrane. org/author-resources, 2016 | 25 | 2016 |
| Gabra2 is a genetic modifier of Scn8a encephalopathy in the mouse W Yu, SF Hill, JG Xenakis, F Pardo‐Manuel de Villena, JL Wagnon, ... Epilepsia 61 (12), 2847-2856, 2020 | 19 | 2020 |
| Genetic interaction between Scn8a and potassium channel genes Kcna1 and Kcnq2 SF Hill, JM Ziobro, P Jafar‐Nejad, F Rigo, MH Meisler Epilepsia 63 (10), e125-e131, 2022 | 13 | 2022 |
| How to GRADE the quality of the evidence. Version 3.0. December 2016 R Ryan, S Hill Cochrane Consumers and Communication Group, available at cccrg. cochrane …, 2016 | 12 | 2016 |
| Cochrane Consumers and Communication Group. How to GRADE the quality of the evidence R Ryan, S Hill | 11 | 2018 |
| Spontaneous seizures and elevated seizure susceptibility in response to somatic mutation of sodium channel Scn8a in the mouse W Yu, CE Smolen, SF Hill, MH Meisler Human Molecular Genetics 30 (10), 902-907, 2021 | 7 | 2021 |
| Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy SF Hill, P Jafar-Nejad, F Rigo, MH Meisler Frontiers in Neuroscience 17, 1282201, 2023 | 5 | 2023 |
| Long‐Term Downregulation of the Sodium Channel Gene Scn8a Is Therapeutic in Mouse Models of SCN8A Epilepsy SF Hill*, W Yu*, J Ziobro, S Chalasani, F Reger, MH Meisler Annals of Neurology 95 (4), 754-759, 2024 | 4 | 2024 |
| Going virtual: Successes and shortcomings of a synchronous STEM outreach event P Prizlow, M Quirk, KJ Schache, S Bhakkad, EC Laub, EL Xu, S Hill Journal of Chemical Education 99 (5), 1990-1997, 2022 | 4 | 2022 |
| Allele‐Specific Editing of a Dominant SCN8A Epilepsy Variant Protects against Seizures and Lethality in a Murine Model W Yu, SF Hill, Y Huang, L Zhu, Y Demetriou, J Ziobro, F Reger, X Jia, ... Annals of Neurology 96 (5), 958-969, 2024 | 1 | 2024 |
